YANIK TEDAVİ MERKEZİNDE ÇOCUK HASTALARDA ANTİBİYOTİK KULLANIMI: ON İKİ YILLIK DENEYİMİMİZ

AMAÇ: Yanık hastalarında antibiyotik kullanımı yara üzerine topikal, sistemik proflaktik veya sistemik tedavi amacıyla olmaktadır. Bu çalışmada merkezimizdeki çocuk yanık hastalarının demografik bulgularını, sistemik tedavi amaçlı antibiyotik kullanım oranlarını ve antibiyotik kullanılan ve kullanılmayan hastaların sonuçlarını karşılaştırmayı amaçladık.GEREÇ VE YÖNTEMLER: Çalışmaya 1 Nisan 2001 ile 31 Aralık 2012 tarihleri arasında 16 yaş ve altı yatarak tedavi edilen hastalar çalışmaya dahil edilmiştir. Hastaların cinsiyeti, yanık nedenleri, ortalama yanık yüzey alanları, hastanede kalış süreleri, mortalite, antibiyotik kullanımları, operasyon varlığı, yara, kan ve idrar kültür sonuçları kayıt altına alındı.BULGULAR: Çalışma süresince 1268 hastanın yatarak tedavi aldığı tespit edildi. Hastaların ortalama yaşı 4,41 ± 3,89 yıldı, bu hastaların 738/1268 (%58,2)'i erkek, 530/1268 (%41,8)'u kızdı. Yatırılarak tedavi edilen hastaların ortalama yanık yüzdeleri %12,2 ±10,8 iken ortalama hastanede kalış süresi 13,9±16,0 gün olarak bulundu. Hastalarda rastlanan en sık yakıcı ajan sıcak sıvı (%81,7) olarak bulunmuştur. Kliniğimizde 255/1268 (%20,1) hastanın tedavisi sürecinde sistemik tedavi amaçlı antibiyotik kullanılmıştır. Hastalarda mortalite 29/1268 (%2,3) olarak tespit edilmiştir.SONUÇ: Kliniğimizin yanık tedavi algoritmasında sistemik veya lokal enfeksiyon bulguları olmayan hastalarda profilaktik sistemik antibiyotik kullanılmamaktadır. Bulgularımıza göre profilaktik antibiyotik kullanımı olmadan elde edilen sonuçların oldukça kabul edilebilir olduğu kanısındayız

THE USE OF ANTIBIOTICS IN PEDIATRIC BURN PATIENTS IN A BURN CENTER: OUR EXPERIENCE IN TWELVE YEARS

OBJECTIVE: The use of antibiotics in burn patients aims topical treatment, systemic prophylaxis or systemic treatment of the burn wounds. In the present study we aimed to compare the demographic characteristics of pediatric burn patients with systemic antibiotic use rate and the effect of antibiotic usage on results.MATERIAL AND METHODS: All burn patients under the age of sixteen patients who were hospitalised between April 1st 2001- December 31st 2012 were enrolled to the study. Patient demographics, cause of burns, total burned body surface area, length of hospitalisation, mortality, the use of systemic antibiotic, the need of surgery, results of blood, wound and urinary cultures were recorded for each patient.RESULTS: A total of 1268 patienst were enrolled to the study. Mean age was 4,41 ± 3,89 years. M/F ratio was 738/530 (58,2% Male, 41,8% Female). Mean total burned body surface area was 12,2 ±10,8 and mean time of hospitalization was 13,9±16,0 days. The most common cause of burn was scald burns in 255 (81,7%) of the patients. Systemic antibiotics were started in 255 (20,1 %) patients and overall mortality was 2,3%.CONCLUSION: The use of prophylactic antibiotics in burn children with no signs of systemic or local infection; is not a part of our treatment algorythm. When we compared the mortality and complşications with antibiotic use; we suggest that teh use of prophylactic antibiotics in burn children is not essential

PDF

___

1)Mock C, Peck M, Peden M, Krug E, Ahuja R, Albertyn H, et al. A WHO plan for burn prevention and care. World Health Organization. Geneva, 2008.
2)Öztorun Cİ, Demir S, Azılı MN, Şenaylı A, Livanelioğlu Z, Şenel E. Türkiye’de Çocuk Yanık Merkezi Olmanın sonuçları. Ulus Travma Acil Cerrahi Derg. 2016; 22: 34-39.
3)Member of the ACCP/SCCM Consensus Conferance Committee: ACCP/SCCM consensus conferance: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992; 20: 864-74.
4)Aldemir M, Kara IH, Girgin S, Güloglu C.Factors affecting mortality and epidemiological data in patients hospitalised with burns in Diyarbakir, Turkey.S Afr J Surg. 2005; 43: 159-62.
5)Kut A, Basaran O, Noyan T, Arda IS, Akgün HS, Haberal M. Epidemiologic analysis of patients with burns presenting to the burn units of a University Hospital Network in Turkey.J Burn Care Res. 2006; 27: 161-9.
6)Türegün M, Sengezer M, Selmanpakoglu N, Celiköz B, Nişanci M. The last 10 years in a burn centre in Ankara, Turkey: an analysis of 5264 cases.Burns. 1997; 23:584-90.
7)Sakallioğlu AE, Başaran O, Tarim A, Türk E, Kut A, Haberal M. Burns in Turkish children and adolescents: nine years of experience.Burns. 2007; 33: 46-51.
8)Haberal M, Uçar N, Bilgin N. Epidemiological survey of burns treated in Ankara, Turkey and desirable burn-prevention strategies.Burns. 1995; 21: 601-6.
9)Epidemiology of paediatric burns in Iran. Karimi H1, Montevalian A, Motabar AR, Safari R, Parvas MS, Vasigh M. Ann Burns Fire Disasters. 2012; 30; 25: 115-20.
10)Childeren with burn injuries-assessment of ruama, neglect, violence anda buse. Toon M.H, Maybauer D.M, Arceneaux L.L, Fraser J.F, Meyeer W., Runge A., Maybauer M.O. Inj Violence Res. 2011; 3: 98-110
11)Mulgrew S, Khoo A, Cartwright R, Reynolds N. Morbidity in pediatric burns, toxic shock syndrome, and antibiotic prophylaxis: a retrospective comparative study.Ann Plast Surg. 2014; 72: 34-7.
12)Avni T1, Levcovich A, Ad-El DD, Leibovici L, Paul M. Prophylacticantibiotics for burnspatients: systematic review and meta-analysis.BMJ. 2010; 15: 340
13)Kimura A, Mochizuki T, Nishizawa K, Mashiko K, Yamamoto Y, Otsuka T. Trimethoprim-sulfamethoxazole for the prevention of methicillin-resistant Staphylococcus aureus pneumonia in severely burned patients. Journal of Trauma. 1998; 45: 383-7.
14)Durtschi MB, Orgain C, Counts GW, Heimbach DM. A prospective study of prophylactic penicillin in acutely burned hospitalized patients. Journal of Trauma. 1982; 22: 11-4.
15)Barajas-Nava LA, López-Alcalde J, Roqué i Figuls M, Solà I, Bonfill Cosp X. Antibiotic prophylaxis for preventingburnwound infection.Cochrane Database Syst Rev. 2013 Jun 6;6:CD008738.
16)Ergün O, Celik A, Ergün G, Ozok G.Prophylactic antibiotic use in pediatricburn units. Eur J Pediatr Surg. 2004; 14: 422-6.
17)Stewart BT, Gyedu A, Agbenorku P, Amankwa R, Kushner AL, Gibran N.Routine systemic antibiotic prophylaxis for burn injuries in developing countries: A best evidence topic (BET).Int J Surg. 2015; 21: 168-72.
18)Paratz JD, Lipman J, Boots RJ, Muller MJ, Paterson DL. A New Marker of Sepsis Post Burn Injury?Crit Care Med. 2014; 42: 2029-36.
19)Alrawi M, Crowley TP, Pape SA. Bacterial colonisation of the burn wound: a UK experience.J Wound Care. 2014; 23: 274-7
20)Rixing Z, Jun W, Yizhi P, Gaoxing L.Advances in the research of early systemic use of prophylacticantibiotics in severe burns]. Zhonghua Shao Shang Za Zhi. 2015; 31: 233-5